Cutaneous Lupus Registry
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT01266915
- Status
- Recruiting
Conditions
- Lupus Erythematosus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Approximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their disease. Cutaneous lupus erythematosus represents the skin manifestations of systemic lupus erythematosus, and can appear in people with or without systemic lupus. It is a mentally, physically, and emotionally debilitating disease that affects both the quality of life and social well-being of those affected. The cause of cutaneous lupus is not completely understood, but likely includes multiple factors from our genes and the environment. Multiple genetic studies with small numbers of cutaneous lupus patients have been performed to determine which genes are associated with cutaneous lupus. This study aims to accumulate even larger numbers of patients to confidently identify genes and the proteins they encode that could contribute greatly to the formation of cutaneous lupus. The discovery of these genes and proteins would help not only uncover how cutaneous lupus forms, but also improve our abilities to diagnose this disease and predict its course, and stimulate new drug development.
Key Dates
- Start date
- Jan 31, 2009
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Control groupNormal disease free (non lupus) subjects
- Arm: Diseased Control
- Arm: Diseased group 1Those subjects with systemic lupus erythematosus.
- Arm: Diseased group 2Subjects diagnosed with cutaneous lupus.
Primary Outcome Measure
Genes [ Time Frame: 5 years ]
Central Contacts
- Benjamin Chong, MD, MSCS214-648-3427
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern Medical Center Dallas | Dallas | Texas | 75390 |
Find similar trials in Dallas, TX
Related Studies
- Trial of Belimumab in Early LupusPHASE4 · Recruiting · Northwell Health · Manhasset, New York
- Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis StressNot Yet Recruiting · Duke University · Durham, North Carolina